SYROS PHARMACEUTICALS

Syros Pharmaceuticals is a biopharmaceutical company engaged in the non-coding regulatory region of the genome to develop a new wave of medicines that control the expression of genes. The company's primary product candidates are: SY-1425, a selective retinoic acid receptor alpha agonist that is used to treat acute myeloid leukemia patients; SY-1365, a selective inhibitor of cyclin-dependent kinase 7 (CDK7), that is being evaluated in a Phase 1 clinical trial in patients with advanced solid tumors; and SY-5609, a CDK7 inhibitor that can be administered orally, which is being evaluated in investigational new drug application, enabling preclinical studies.
  • TickerSYRS
  • ISINUS87184Q1076
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

Wedbush Research

Wedbush Morning Call - May 26 2020 6:20AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

Wedbush Research

Wedbush Morning Call - May 18 2020 6:54AM

Syros Pharmaceuticals Inc: 1 director bought

A director at Syros Pharmaceuticals Inc bought 10,000 shares at 8.859USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The na...

Wedbush Research

Wedbush Morning Call - May 26 2020 6:20AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Wedbush Research

Wedbush Morning Call - May 18 2020 6:54AM

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Kambiz Yazdi
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ValuEngine Rating and Forecast Report for SYRS

ResearchPool Subscriptions

Get the most out of your insights

Get in touch